Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of 18F-DCFPyL PET/CT in Men With Elevated PSA After Radical Prostatectomy
NCT02523924Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jun 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoints: Number of Putative Sites of Metastatic Disease as Determined by 18F-DCFPyL PET/CT at 6 months and Location of Putative Sites of Metastatic Disease as Determined by 18F-DCFPyL PET/CT at 6 months. Started Jun 2015; status: completed.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02523924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02523924.